Merry Christmas everyone with a new #WednesdayWagner instalment. Today: TRISTAN CHORD IN 'DIE WALKÜRE'! What happens next will surprise you
#Christmas #Wagner #Tristan #Walkure #TwitterCultural

@ImPranav_M @GunduHuDuGa That's a good qsn, if not a bit nuanced. Avataras are of many varieties and frankly, most of the classification is only for our understanding and not really binding on Paramatma Himself. We can take several approaches to understanding this. If you go by a Vedantic approach,+

@GunduHuDuGa Avatara means that which descends from an exalted state (Taara). Going by Upanishadic observaton of Purnam adham purnam idham, every manifestation of Bhagavan is indeed wholesome. In fact, Avataras usually happen when Iswara is propitiated with certain qualities already+

@GunduHuDuGa described in the Vedas by other Devatas. So, in order to please them, He assumes the form that best envisages the said Vaidika tatvam. For example, Varaha and Nrusimha avatars, though they have sthoola prayojanas, also exemplify the Tejovanna tatvam propounded by Upanishads.+

@GunduHuDuGa All these tatvams ultimately emanate from Him so whatever form He takes is indeed Purna. Now, one may ask then if that's the case, why such a distinction had to be made in the first place. That is because of upasana vidhis and understanding of how Bhagavad tatvam shines+

@GunduHuDuGa with each Leela being performed. Let's take Nrusimha avatar. The purpose of the avatar is neither to save Hiranyakasipu nor rescue Prahlada. For that He need not descend down as H's boons are applicable only for Brahman's creation and not Paramatma Himself.+

#SuvenLife – Niche R&D play..very high risk and very high reward…key is right allocation…

Jazz Pharma was quoting around $0.5 in 2009, today its $150 and Mcap of $8.5 Bn on Nasdaq..almost 300x in 11 years. 80% of its total sales ($2.1 Bn) come from single drug Xyrem.

Axovant Lifescience, bought Alzheimer molecule from GSK, repackaged it and done phase-3 trials. Before starting the trials, the valuation was $2 Bn, just before announcing the data, it rose to $3 Bn. One of the leading broker put the target of $12 Bn if the trials succeeded..

but it failed in phase-3 trials. Current Mcap is $120 Mn…

This is R&D for New Chemical Entity (NCE)…very high risk and very high reward…

Brain-related illnesses, also known as CNS diseases, afflict more than 2 billion people worldwide. Diseases of the brain and mind range

from Alzheimer’s, dementia, epilepsy, migraine, multiple sclerosis, neuro infections, Parkinson’s, psychosis, schizophrenia and stroke to brain injuries and various mental disorders. The global market or CNS therapeutics is projected to reach $137.7 billion by 2025.

#SuvenLife has 1 lead molecule SUVN-G3031 in phase-2 trials which is similar to Xyrem but superior features, 3 molecules completed phase-1 trials and starting phase-2 trials and 11 molecules in pre-clinical trials. All are related to CNS which is growing and uncluttered market

THREAD ON IRONFLY

These days the most preferred strategy for option sellers due to improved margins is IRONFLY. It's essentially a short straddle with long strangle. Long strangle acting as 'WINGS', which help in capping the unlimited risk associated with a short straddle.(1/n)

You can also view the position as a combination of Cal & Put credit spreads, if that makes it more easy for you.

There are 3 important things to understand while trading this strategy:

1) Initial size of the Wings
2) Risk Management
3) Adjustments

(2/n)

Since we are selling an ATM straddle, the 1st question is how far our wings should be? Ideally i sell .50 delta straddle & buy .20 or .10 OTM strangle, depending on my view on volatility. So the distance of wings depends on the IV setup. Higher the IVs, greater the distance.(3/n)

If you don't understand greeks, then ideally with 30 days to expiry (dte), wings should be around 300pts either side. If your trading in weekly then it should be not more than 200pts. Higher the premiums, higher the distance as we have more cushion of theta. (4/n)

It is important to understand that we need to reduce the distance of wings with time so as to manage our RISK in gap openings or sudden volatile move. So for eg. if you started with 300pt wings with 30dte, the wings wouldn't give the same protection when there is 7dte. (5/n)